BMC Biotechnology

Section Editors

Joaquim M Cabral, Instituto Superior Tecnico
Dhinakar S Kompala, University of Colorado
Lluis Montoliu, Centro Nacional de Biotecnologia
Mats Nilsson, Uppsala University
Peter J Punt, TNO Quality of Life
Marko Radic, University of Tennessee
John J Rossi, Beckman Research Institute City of Hope
Igor Stagljar, University of Toronto
C Neal Stewart, University of Tennessee

Executive Editor

Dafne Solera, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Engineered T cells against leukemia

Marko Radic discusses recent advances in cancer immunotherapy, whereby cytotoxic T cells from patients with leukemia are turned into efficient and specific killers of their own cancer cells.

BMC Biotechnology 2012, 12:6
Bacterial protein detects enteric viruses

A broad spectrum virus-binding protein derived from the bacterial chaperon protein GroEL and able to bind rotavirus, norovirus and poliovirus, could be used to detect diverse enteric viruses simultaneously in water and fecal samples.

BMC Biotechnology 2011, 11:123
Transgenic bacteria clean up mercury

Engineered bacteria expressing the heavy metal scavenging molecules metallothionein or polyphosphate kinase are resistant to mercury and can detoxify their environment by accumulating most of the toxic element, which could be subsequently recycled for further industrial applications.

BMC Biotechnology 2011, 11:82

RSS

Comments

Abstract correction

Comment on: Rocha-Martín et al. BMC Biotechnology 2011, 11:101
Correction

Comment on: van der Voet et al. BMC Biotechnology 2011, 11:15
current adress

Comment on: Borejsza-Wysocka et al. BMC Biotechnology 2010, 10:41

RSS

News from the web

08 February 2012: Flipping a light switch in the cell: Quantum dots used for targeted neural activation

18 January 2012: Scripps research scientists create novel RNA repair technology

11 January 2012: Fewer animal experiments thanks to nanosensors

Scope

BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.

RSS

From the blog

08 February 2012: Invitation to submit to Cancer Bioinformatics thematic series

30 January 2012: BMC-series journals on track for Impact Factor

18 January 2012: Bacterial symbionts – the key to fighting pests and diseases?

Quote

"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA